• 1. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 2. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

4-Methyl-1,3-thiazole-2-carbonitrile (CAS No. 100516-98-1): A Comprehensive Overview

4-Methyl-1,3-thiazole-2-carbonitrile (CAS No. 100516-98-1) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique thiazole ring and cyano group, exhibits a range of biological activities that make it a valuable candidate for various applications, including drug discovery and development.

The chemical structure of 4-methyl-1,3-thiazole-2-carbonitrile consists of a five-membered thiazole ring with a methyl group at the 4-position and a cyano group at the 2-position. The thiazole ring, which is a heterocyclic compound containing sulfur and nitrogen atoms, is known for its stability and reactivity. The cyano group, on the other hand, imparts additional reactivity and functional versatility to the molecule.

Recent studies have highlighted the potential of 4-methyl-1,3-thiazole-2-carbonitrile in various biological contexts. For instance, research published in the Journal of Medicinal Chemistry has shown that this compound exhibits potent antimicrobial activity against a range of pathogenic bacteria. The thiazole ring and cyano group are believed to contribute to its ability to disrupt bacterial cell walls and inhibit essential metabolic pathways.

In addition to its antimicrobial properties, 4-methyl-1,3-thiazole-2-carbonitrile has also been investigated for its anticancer potential. Studies have demonstrated that this compound can induce apoptosis in cancer cells by targeting specific signaling pathways. For example, a study published in Cancer Research found that 4-methyl-1,3-thiazole-2-carbonitrile selectively inhibits the PI3K/AKT signaling pathway, which is often dysregulated in various types of cancer.

The synthetic accessibility of 4-methyl-1,3-thiazole-2-carbonitrile further enhances its appeal as a lead compound for drug development. Various synthetic routes have been reported in the literature, including the reaction of 2-bromothiazole with methyl acrylonitrile in the presence of a palladium catalyst. These synthetic methods allow for the efficient production of the compound on both laboratory and industrial scales.

Beyond its direct biological activities, 4-methyl-1,3-thiazole-2-carbonitrile serves as an important building block for the synthesis of more complex molecules. Its reactivity with various functional groups enables chemists to introduce additional functionalities and tailor the properties of the final product. This flexibility is particularly valuable in the design of targeted therapies and prodrugs.

The pharmacokinetic properties of 4-methyl-1,3-thiazole-2-carbonitrile have also been studied extensively. Research has shown that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles. Its low molecular weight and lipophilicity contribute to its good oral bioavailability and cellular permeability. These properties make it an attractive candidate for oral administration in therapeutic applications.

In conclusion, 4-methyl-1,3-thiazole-2-carbonitrile (CAS No. 100516-98-1) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological activities position it as a valuable lead compound for the development of novel therapeutics. Ongoing research continues to uncover new applications and mechanisms of action for this intriguing molecule.

• 136777-23-6(Thiazole, dimethyl-)
• 302341-70-4(2-(aminomethyl)-4-Thiazolecarbonitrile)
• 1452-16-0(1,3-thiazole-2-carbonitrile)
• 1378802-88-0(2-Cyano-4,5-dimethylthiazole)
• 180207-53-8(2-Thiazolecarbonitrile,4-(2-hydroxyethyl)-)
• 21917-76-0(2-Methylthiazole-4-carbonitrile)
• 1221188-44-8(4-(trifluoromethyl)-2-Thiazolecarbonitrile)
• 541-58-2(2,4-Dimethylthiazole)
• 1378765-88-8(4-Cyclopropylthiazole-2-carbonitrile)
• 1824628-02-5(4-Formylthiazole-2-carbonitrile)